Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning
- PMID: 24842943
- DOI: 10.1161/CIRCULATIONAHA.114.008201
Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning
Abstract
Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. The associated morbidity and mortality make AF a major public health burden. Hospitalizations account for the majority of the economic cost burden associated with AF. The main objective of this study is to examine the trends of AF-related hospitalizations in the United States and to compare patient characteristics, outcomes, and comorbid diagnoses.
Methods and results: With the use of the Nationwide Inpatient Sample from 2000 through 2010, we identified AF-related hospitalizations using International Classification of Diseases, 9th Revision, Clinical Modification code 427.31 as the principal discharge diagnosis. Overall AF hospitalizations increased by 23% from 2000 to 2010, particularly in patients ≥65 years of age. The most frequent coexisting conditions were hypertension (60.0%), diabetes mellitus (21.5%), and chronic pulmonary disease (20.0%). Overall in-hospital mortality was 1%. The mortality rate was highest in the group of patients ≥80 years of age (1.9%) and in the group of patients with concomitant heart failure (8.2%). In-hospital mortality rate decreased significantly from 1.2% in 2000 to 0.9% in 2010 (29.2% decrease; P<0.001). Although there was no significant change in mean length of stay, mean cost of AF hospitalization increased significantly from $6410 in 2001 to $8439 in 2010 (24.0% increase; P<0.001).
Conclusions: Hospitalization rates for AF have increased exponentially among US adults from 2000 to 2010. The proportion of comorbid chronic diseases has also increased significantly. The last decade has witnessed an overall decline in hospital mortality; however, the hospitalization cost has significantly increased.
Keywords: atrial fibrillation; cost; hospitalization.
© 2014 American Heart Association, Inc.
Comment in
-
Atrial fibrillation epidemic and hospitalizations: how to turn the rising tide?Circulation. 2014 Jun 10;129(23):2361-3. doi: 10.1161/CIRCULATIONAHA.114.010073. Epub 2014 May 19. Circulation. 2014. PMID: 24842944 No abstract available.
Similar articles
-
Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.Adv Ther. 2011 Oct;28(10):907-26. doi: 10.1007/s12325-011-0065-6. Epub 2011 Sep 30. Adv Ther. 2011. PMID: 21971681
-
Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015.Heart. 2018 Dec;104(24):2010-2017. doi: 10.1136/heartjnl-2017-312930. Epub 2018 Apr 17. Heart. 2018. PMID: 29666179
-
Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.Circulation. 2003 Aug 12;108(6):711-6. doi: 10.1161/01.CIR.0000083722.42033.0A. Epub 2003 Jul 28. Circulation. 2003. PMID: 12885749
-
Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future.Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):105-16. doi: 10.1016/j.pcad.2015.07.002. Epub 2015 Jul 8. Prog Cardiovasc Dis. 2015. PMID: 26162957 Review.
-
Atrial fibrillation: public health implications.Am J Prev Med. 2005 Dec;29(5 Suppl 1):75-80. doi: 10.1016/j.amepre.2005.07.021. Am J Prev Med. 2005. PMID: 16389130 Review.
Cited by
-
Impact of lifestyle risk factors on atrial fibrillation: Mechanisms and prevention approaches - A narrative review.Int J Cardiol Cardiovasc Risk Prev. 2024 Oct 24;23:200344. doi: 10.1016/j.ijcrp.2024.200344. eCollection 2024 Dec. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39534719 Free PMC article. Review.
-
Comparative Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients with Chronic Liver Disease: A Systematic Review and Meta-analysis.J Innov Card Rhythm Manag. 2024 Oct 15;15(10):6052-6061. doi: 10.19102/icrm.2024.15103. eCollection 2024 Oct. J Innov Card Rhythm Manag. 2024. PMID: 39502439 Free PMC article. Review.
-
Anticoagulation Therapy Timing in patients with Atrial Fibrillation after Acute and Chronic Subdural Haematoma (ATTAACH): a pilot randomised controlled trial.BMJ Open. 2024 Oct 22;14(10):e090224. doi: 10.1136/bmjopen-2024-090224. BMJ Open. 2024. PMID: 39438108 Free PMC article. Clinical Trial.
-
Edoxaban pharmacokinetics during in vitro continuous renal replacement therapy.BMC Nephrol. 2024 Oct 10;25(1):341. doi: 10.1186/s12882-024-03777-7. BMC Nephrol. 2024. PMID: 39390394 Free PMC article.
-
Management strategies and outcomes of thromboembolism prevention in atrial fibrillation co-existing with immune thrombocytopenia: A review of evidence.Int J Cardiol Heart Vasc. 2024 Aug 22;54:101493. doi: 10.1016/j.ijcha.2024.101493. eCollection 2024 Oct. Int J Cardiol Heart Vasc. 2024. PMID: 39263408 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
